Clinical Trials

Phase 1 Not yet recruiting

Lung Neoplasms

NCT06743555 2026-04-28

SAVED LUNG

14 enrolled

Phase 2 Active not recruiting

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT05882513 2026-04-24

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06114108 2026-04-02

salVage

Phase NA Recruiting

128 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07472478 2026-03-16

GIVEN

32 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06083454 2026-03-13

Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Terminated

1 enrolled

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07432802 2026-02-27

STRADOS

182 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06918132 2026-02-24

N-PLANC

60 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06810609 2026-01-27

InDuRanS

176 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07073365 2025-12-30

BOOST

70 enrolled

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07272356 2025-12-09

Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function

68 enrolled

Carcinoma, Non-Small-Cell Lung, Respiratory Aspiration

NCT07264647 2025-12-04

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

NCT07241819 2025-11-21

Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

66 enrolled

II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer

NCT07177092 2025-09-16

SURGAN-TKI

118 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04830826 2025-07-30

ADDRESS

Completed

1,490 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07089199 2025-07-28

TitAN

34 enrolled

Phase 2/3 Active not recruiting

NSCLC

NCT07076693 2025-07-22

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

97 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

36 enrolled

Phase 2 Active not recruiting

Unresectable Non-small Cell Lung Cancer

NCT04062708 2025-07-08

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07038460 2025-06-26

NEO-LISI

134 enrolled

Phase 3 Active not recruiting

Resectable Non-small Cell Lung Cancer

NCT03800134 2025-06-11

AEGEAN

825 enrolled 1 FDA

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT06998719 2025-05-31

ACCESS

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06944470 2025-04-25

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

76 enrolled

NSCLC

NCT06939127 2025-04-22

Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06911606 2025-04-04

Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

45 enrolled

SCLC, Limited Stage

NCT06908070 2025-04-03

CROWD

Phase 4 Recruiting

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06837948 2025-02-20

Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC

160 enrolled

Locally Advanced Non-Small Cell Lung Cancer

NCT02887521 2025-02-03

Pulmonary Rehabilitation Before Lung Cancer Resection

Phase 3 Terminated

9 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung, Pulmonary Disease, Chronic Obstructive

NCT06341933 2025-01-30

Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection

Recruiting

100 enrolled

GenitourinaryThoracic

Lung Neoplasms, Acute Kidney Injury

NCT01753414 2025-01-06

POSTILV

Phase 2 Unknown

44 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02428764 2024-12-10

Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma

Phase 2 Withdrawn

Phase 2 Active not recruiting

Lung Neoplasms

NCT01553942 2024-11-20

Afatinib With CT and RT for EGFR-Mutant NSCLC

19 enrolled

Lung Neoplasms

NCT02488850 2024-11-07

HAMLET

Phase NA Completed

32 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03217071 2024-10-23

Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer

Phase 2 Completed

12 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT06621147 2024-10-01

MLA-MNSCLCNET

Completed

1,776 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05974475 2024-09-23

MONDRIAN

Recruiting

270 enrolled

Lung Neoplasms

NCT05766800 2024-09-19

Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06591910 2024-09-19

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Not yet recruiting

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06534489 2024-08-02

Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment

Recruiting

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06256237 2024-05-29

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial

Phase NA Active not recruiting

Small Cell Lung Carcinoma

NCT04945928 2024-05-24

Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC

Lung Neoplasms

NCT06394427 2024-05-01

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

Unknown

250 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06357598 2024-04-10

PILOT

Phase 4 Unknown

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT06282536 2024-02-28

Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00030771 2024-01-17

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Phase 3 Completed

232 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06109402 2023-12-19

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

160 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06023797 2023-09-05

Neoadjuvant Immunochemotherapy for Lung Cancer

Completed

83 enrolled

Lung Neoplasms

NCT05891080 2023-06-06

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

124 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05496166 2023-05-17

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

348 enrolled